Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

520

Citations

26

References

2017

Year

Stephen Bagley, Shawn Kothari, Charu Aggarwal, Joshua Bauml, Evan Alley, Tracey L. Evans, John A. Kosteva, Christine Ciunci, Peter Gabriel, Jeffrey C. Thompson,

Pretreatment Neutrophil-to-lymphocyte RatioCancer ImmunosurveillanceGranulocyteMedicineImmunologyNivolumab-treated PatientsImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1

Page 1